Octave Specialty Q4 2025: Net loss from continuing ops $29.98M, adjusted EBITDA improves to $1.35M

OCTAVE SPECIALTY GROUP INC

2025-FY EPS reported -$5.93 revenue$251,222,000

Revenue $66.9M (+3% YoY); net loss from continuing ops to shareholders $29.98M (diluted EPS -$0.84) vs loss $22.16M (EPS -$0.56) last Q4.
Insurance Distribution: premium production $303M (+15%), commission income $37M (+13%), organic growth 8.1%, segment adjusted EBITDA $7M (+33%).
Everspan: gross premiums written $80M (+34%), net premiums written $23M (+978%), combined ratio below 100%, net income fell 37% to $1M.
Adjusted EBITDA to shareholders $1.35M vs $0.52M; driven by ID segment improvement and corporate cost reductions.
Acquired ArmadaCare and launched 1889 Specialty MGA in Q4; expects strong organic growth in 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.